Lv2
108 积分 2024-09-14 加入
Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond
9天前
已完结
Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases
17天前
已完结
Prospects for PARG inhibitors in cancer therapy
20天前
已完结
The diacylglycerol kinase ζ inhibitor ASP1570 augments natural killer cell function
25天前
已完结
Artificial intelligence in drug development
1个月前
已完结
Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities
2个月前
已完结
The Aryl Hydrocarbon Receptor (AHR) as a Potential Target for the Control of Intestinal Inflammation: Insights from an Immune and Bacteria Sensor Receptor
2个月前
已完结
Genome doubling shapes the evolution and prognosis of advanced cancers
2个月前
已完结
Design, Biological Characterization, and Discovery of Novel Cyclohexenyl Derivatives as Kinesin KIF18A Inhibitors for the Treatment of Ovarian Cancer
3个月前
已完结
Exploratory studies with NX-13: oral toxicity and pharmacokinetics in rodents of an orally active, gut-restricted first-in-class therapeutic for IBD that targets NLRX1
3个月前
已完结
皖公网安备34019202002308
